In vitro and in vivo potency of polymyxin B against IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa

International Journal of Antimicrobial Agents

Volumn 32, Issue 5, 2008, Pages 437-440

  Miyajima, Yoshiko ^a   Hiramatsu, Kazufumi ^a   Mizukami, Eri ^a   Morinaga, Ryotaro ^a   Ishii, Hiroshi ^a   Shirai, Ryo ^a   Kishi, Kenji ^a   Tokimatsu, Issei ^a   Saikawa, Tetsunori ^b   Kadota, Jun ichi ^a  

^a OITA UNIVERSITY   (Japan)

^b OITA UNIVERSITY HOSPITAL   (Japan)

Author keywords

IMP type metallo lactamase; Polymyxin B; Pseudomonas aeruginosa

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFOPERAZONE; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COLISTIN; CYCLOPHOSPHAMIDE; IMIPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL COUNT; BACTERIUM ISOLATE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SURVIVAL RATE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; COLISTIN; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; MALE; MICE; MICROBIAL SENSITIVITY TESTS; POLYMYXIN B; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS;

EID: 53449083524     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.05.006     Document Type: Article

References (15)

1. Obritsh M.D., Fish D.N., MacLaren R., and Jung R. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother 48 (2004) 4606-4610
2. Tsujii A., Kobayashi I., Oguri T., Inoue M., Yabuuchi E., Goto S., et al. An epidemiological study of the susceptibility and frequency of multiple-drug-resistant strains of Pseudomonas aeruginosa isolated at medical institutes nationwide in Japan. J Infect Chemother 11 (2005) 64-70
3. Kimura S., Alba J., Shiroto K., Sono R., Niki Y., Maesaki S., et al. Clonal diversity of metallo-β-lactamase-possessing Pseudomonas aeruginosa in geographically diverse regions of Japan. J Clin Microbiol 43 (2005) 458-461
4. Nishio H., Komatsu M., Shibata N., Shimakawa K., Sueyoshi N., Ura T., et al. Metallo-β-lactamase-producing Gram-negative bacilli: laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan. J Clin Microbiol 42 (2004) 5256-5263
5. Kallel H., Bahloul M., Hergafi L., Akrout M., Ketata W., Chelly H., et al. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU. Int J Antimicrob Agents 28 (2006) 366-369
6. Giamarellos-Bourboulis E.J., Sambatakou H., Galani I., and Giamarellou H. In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa. J Chemother 15 (2003) 235-238
7. Furtado G.H.C., Azevedo P.A., Santos A.F., Gales A.C., Pignatari A.C.C., and Medeiros E.A.S. Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. Int J Antimicrob Agents 30 (2007) 315-319
8. IMP) in gram-negative rods resistant to broad-spectrum β-lactams. J Clin Microbiol 34 (1996) 2909-2913
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. M100-S17. Wayne, PA: CLSI; 2007.
10. Eickhoff T.C., and Finland M. Polymyxin B and colistin: in vitro activity against Pseudomonas aeruginosa. Am J Med Sci 249 (1965) 172-174
11. Duncan I.B.R. Susceptibility of 1 500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin and polymyxin B. Antimicrob Agents Chemother 5 (1974) 9-15
12. Hogardt M., Schmoldt S., Gotzfried M., Adler K., and Heesemann J. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother 54 (2004) 1057-1061
13. Tam V.H., Schilling A.N., Vo G., Kabbara S., Kwa A.L., Wiederhold, et al. Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa. Antimicrob Agents Chemother 49 (2005) 3624-3630
14. Gilad J., Eskira S., Riesenberg K., Schlaeffer F., Hyam E., and Borer A. Emergence of nosocomial colistin-resistant Acinetobacter baumannii. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). 16-19 December 2005; Washington, DC (2005), ASM Press, Washington, DC 333
15. Omri A., Suntres Z.E., and Shek P.N. Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem Pharmacol 64 (2002) 1407-1413